Skip to main content
. 2018 Sep 30;19(10):2996. doi: 10.3390/ijms19102996

Figure 8.

Figure 8

Figure 8

Cell viability of A549 cells treated with HSP70/90 family inhibitors, (A,B) VER155008 (HSP70 family; GRP75 and HSP70), (C,D) HA15 (GRP78) and (E,F) NVP-BEP800 (HSP90 family; GRP94, HSP90 and trap-1) in human MSC-CM during hypoxic (0.5% O2) exposure for 24 h. The viability of A549 cells was assessed via MTT assay. Data presented as mean  ±  SD; n = 3 (*** p  <  0.001 vs. normoxia control; and # p  <  0.05, ### p  <  0.001 vs. hypoxia control and † p  <  0.05, †† p  <  0.01, ††† p  <  0.001 vs. BMSC-CM / vehicle or ADSC-CM / vehicle). The resulting data were statistically analysed using one-way ANOVA and Tukey’s multiple comparison test.